Incyte Reports Fourth Quarter and Year-End 2022 Financial Performances

WILMINGTON Del., January 17, 20,23–(BUSINESS WIRE)–Incyte (Nasdaq:INCY) announced today that it has scheduled its fourth quarter and year-end 2022 financial results conference call and webcast for 8:00 a.m. ET on Tuesday, February 7, 20,23

Here is the schedule for the conference call/webcast and press release:

• Q4 & YE 2022 Press Release: February 7, 2023 at 7:00 a.m. ET

• Q4 & YE 2022 Conference Call: February 7, 2023 at 8:00 a.m. ET

• Domestic dial-in Number: 877-407-3042

• International Dial-In number: 201-389-0864

• Conference ID Number: 13735569

You can replay the conference call for up to 30 days if your phone is not working. For international callers, the number is 201-612-7151.. You will need the conference ID number 1373569 to access the replay.

You can access the live webcast with slides at Investor.Incyte.com The replay will be available for 90 days.

About Incyte
Incyte, a global biopharmaceutical company based in Wilmington, Delaware, focuses on solving serious unmet medical problems through the development, commercialization, and discovery of therapeutics. Visit www.incyte.com for more information. Incyte.com Follow these steps @Incyte.

Visit businesswire.com to see the source version https://www.businesswire.com/news/home/20230117005125/en/

Contacts

Contacts with Incyte
Media
Catalina Loveman
+1 302 498 6171
[email protected]

Investors
Christine Chiou
+1 302 274 4773
[email protected]